Wednesday, September 16, 2009

SELLING VYTORIN THROUGH $60 M OF CME

Arteries Clogged by Moolah


Cardiobrief, via Dow Jones newswire, reports on the extraordinary sums MSP provided to CME related to Vytorin. One single grant amount to $6 M.

See: http://cardiobrief.org/2009/09/16/senate-investigation-uncovers-huge-expenditures-for-vytorin-cme/

The information emerged through a Senate investigation.

I'm glad that pharma is supporting health-care reform.
Posted by Henry (Hank) Greenspan at 5:16 PM
Labels: , , ,

4 comments:

  1. HalfababySeptember 16, 2009 at 7:57 PM

    I ordered "Worst Pills, Best Pills," but all I got was a newsletter. Not a single capsule.

    What gives?

    ReplyDelete
  2. AnonymousSeptember 16, 2009 at 9:09 PM

    If you want to remove big pharma's influence on CME, just change the tax code so it's no longer tax deductible. The expenditures will dry up overnight.

    ReplyDelete
  3. SolSeptember 18, 2009 at 4:53 PM

    Halfababy, you got lucky...

    ReplyDelete
  4. ObserverSeptember 18, 2009 at 5:26 PM

    From an article linked in Justice’s posting:

    “A recent hearing of the Senate Aging Committee on continuing medical education (CME) should scare anyone who might need to see a doctor in the next few years. But you don’t need to be a Washington policy wonk to discover that there’s a huge problem with CME.” See: http://cardiobrief.org/2009/08/25/editorial-prescription-for-medical-education-sunshine/

    ReplyDelete

Note - Due to a time out issue with Blogger, you may receive a message that requires you to resend your comment. This will not affect its contents.

Subscribe to: Post Comments (Atom)